Sleep-Related Drug Therapy in Special Conditions: Children

Nicholas-Tiberio Economou1, Luigi Ferini-Strambi2, Paschalis Steiropoulos3

  • 1Sleep Unit, Department of Psychiatry, University of Athens, 74 Vas Sofias Avenue, Athens 11528, Greece; Enypnion Sleep-Epilepsy Center, Bioclinic Hospital Athens, 15 M. Geroulanou Street, Athens 11524, Greece.

Sleep Medicine Clinics
|September 23, 2022
PubMed

Insights

Evidence-based pharmacologic treatments for common pediatric sleep disorders are limited. Alternative therapies are often preferred for managing symptoms and supporting children

Area of Science:

  • Pediatric Sleep Medicine
  • Child Development
  • Pharmacology

Background:

  • Pediatric sleep disorders are prevalent and can significantly impair cognitive and social development.
  • Current pharmacologic treatments for common childhood sleep issues lack robust evidence.
  • There is a critical need for evidence-based guidelines in managing pediatric sleep disturbances.

Purpose of the Study:

  • To summarize the current therapeutic strategies for pediatric sleep disorders.
  • To highlight the challenges posed by the lack of evidence-based guidelines.
  • To inform clinical practice regarding the management of sleep disorders in children.

Main Methods:

  • Review of current literature on pediatric sleep disorder management.
  • Analysis of existing therapeutic approaches, including non-pharmacologic interventions.
  • Synthesis of information in the absence of established evidence-based guidelines.

Main Results:

  • Pharmacologic interventions for common pediatric sleep disorders are not well-supported by evidence.
  • Alternative and non-pharmacologic methods are frequently employed and show efficacy.
  • The absence of specific guidelines complicates optimal treatment selection.

Conclusions:

  • Current therapeutic management relies heavily on alternative methods due to limited evidence for pharmacologic treatments.
  • Establishing evidence-based guidelines is crucial for addressing the high prevalence and impact of pediatric sleep disorders.
  • Further research is needed to develop and validate effective treatments for children's sleep issues.

Related Concept Videos

Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
312
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
231
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
591
Sleep-Wake Cycles01:24

Sleep-Wake Cycles

Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and  rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
1.5K
Narcolepsy01:07

Narcolepsy

Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
180
CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
432